
Venture capital · Early to growth stage · Est. 2020
Medical Excellence Capital
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Medical Excellence Capital right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
BetaRounds Medical Excellence Capital joined, from press and the firm’s own posts.
3 rounds in the last 12 months
Round sizes, Medical Excellence Capital’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Medical Excellence Capital backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Medical Excellence Capital
Events where Medical Excellence Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Medical Excellence Capital is based in the United States.
In 2020.
1 fund vehicle is on public registers (SEC adviser filings), including MEDICAL EXCELLENCE CAPITAL PARTNERS, LP.
Stages: Seed, Series A, Series B. Sectors: Life sciences, Biotech, AI, Health tech. From the firm’s own website.
MEC looks for disruptive life science technologies and puts capital into high-potential companies, aiming to speed their growth and maximize value. It targets transformative approaches to patient care that address large unmet needs, including through company creation. From the firm’s own website.
Medical Excellence Capital lists 13 portfolio companies on its website, including Aspen Neuroscience, Avilar Therapeutics, ClicBio, GC Therapeutics and Immunitas Therapeutics.
Firms whose websites list some of the same companies include ARCH Venture Partners, 2048 Ventures and Agent Capital.
Know before Medical Excellence Capital’s next round is announced.
PRO tracks Medical Excellence Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.